Van ECK Associates Corp Has $5.60 Million Holdings in Stericycle, Inc. (NASDAQ:SRCL)

Van ECK Associates Corp lifted its holdings in Stericycle, Inc. (NASDAQ:SRCL) by 26.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 106,154 shares of the business services provider’s stock after acquiring an additional 22,166 shares during the period. Van ECK Associates Corp owned approximately 0.11% of Stericycle worth $5,600,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. Strategic Blueprint LLC lifted its position in Stericycle by 6.2% during the fourth quarter. Strategic Blueprint LLC now owns 5,609 shares of the business services provider’s stock worth $278,000 after purchasing an additional 326 shares during the period. Raymond James Financial Services Advisors Inc. lifted its position in Stericycle by 4.9% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 7,243 shares of the business services provider’s stock worth $359,000 after purchasing an additional 336 shares during the period. Retirement Systems of Alabama lifted its holdings in shares of Stericycle by 0.3% in the fourth quarter. Retirement Systems of Alabama now owns 115,880 shares of the business services provider’s stock worth $5,743,000 after acquiring an additional 355 shares during the last quarter. Treasurer of the State of North Carolina lifted its holdings in shares of Stericycle by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 40,838 shares of the business services provider’s stock worth $2,024,000 after acquiring an additional 400 shares during the last quarter. Finally, Blue Trust Inc. lifted its holdings in shares of Stericycle by 15.4% in the fourth quarter. Blue Trust Inc. now owns 3,125 shares of the business services provider’s stock worth $155,000 after acquiring an additional 416 shares during the last quarter. 98.82% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SRCL has been the subject of a number of research reports. Truist Financial increased their target price on shares of Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a report on Tuesday, June 4th. Robert W. Baird dropped their price objective on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a report on Friday, April 26th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. StockNews.com began coverage on shares of Stericycle in a report on Saturday, June 29th. They issued a “hold” rating for the company. Finally, Keefe, Bruyette & Woods increased their target price on shares of Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research report on Tuesday, June 4th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $74.00.

Stericycle Trading Down 0.0 %

NASDAQ:SRCL traded down $0.02 on Friday, reaching $58.39. 458,830 shares of the stock traded hands, compared to its average volume of 985,503. Stericycle, Inc. has a 1-year low of $37.78 and a 1-year high of $59.45. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11. The company’s 50 day moving average is $52.48 and its 200-day moving average is $51.02.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, topping the consensus estimate of $0.54 by $0.03. The company had revenue of $664.90 million during the quarter, compared to the consensus estimate of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The company’s quarterly revenue was down 2.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.49 EPS. Research analysts expect that Stericycle, Inc. will post 2.32 earnings per share for the current fiscal year.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.